From: sRAGE and early signs of cardiac target organ damage in mild hypertensives
Hypertensive patients (n = 100) | Normotensive subjects (n = 100) | p | |
---|---|---|---|
ISWT (mm) | 10.0 ± 1.5 | 9.2 ± 1.3 | 0.001 |
PWT (mm) | 8.8 ± 1.2 | 8.2 ± 1.5 | 0.001 |
LVEDD (mm) | 45.5 ± 4.3 | 45.9 ± 4.8 | 0.440 |
LVEDV (ml) | 94.4 ± 25.6 | 92.0 ± 27.0 | 0.698 |
LVM (g) | 146.1 ± 38.4 | 133.1 ± 35.6 | 0.056 |
LVM/BSA (g/m2) | 78.6 ± 15.5 | 72.9 ± 15.5 | 0.017 |
LVMi (g/m2.7) | 35.0 ± 7.3 | 32.8 ± 7.4 | 0.065 |
RWT | 0.40 ± 0.1 | 0.36 ± 0.1 | < 0.001 |
EF (%) | 63.1 ± 4.9 | 63.6 ± 5.3 | 0.984 |
MWFS | 17.0 ± 3.7 | 19.5 ± .4.6 | < 0.001 |
E/A | 1.1 ± 0.3 | 1.3 ± 0.6 | 0.028 |
Septum E′/A′ | 0.9 ± 0.3 | 1.1 ± 0.4 | < 0.001 |
Septum E/E′ | 7.2 ± 1.6 | 7.2 ± 5.6 | 0.993 |
Lateral E′/A′ | 1.3 ± 0.5 | 1.5 ± 0.5 | 0.094 |
Lateral E/E′ | 5.1 ± 1.4 | 5.1 ± 1.4 | 0.651 |
LAD (mm) | 33.1 ± 4.1 | 33.2 ± 4.1 | 0.710 |
LAV 4C (ml) | 40.4 ± 12.8 | 38.9 ± 13.7 | 0.479 |
LAVi (ml/m2) | 21.9 ± 6.2 | 21.1 ± 6.9 | 0.507 |